CLINICAL AND PATHOGENETIC ASPECTS OF PREMATURE AND EARLY MENOPAUSE. WAYS OF CORRECTION

Authors

  • Nabiеva Diyora Yuldash kizi Andijan State Medical Institute
  • Kayumova Dilrabo Talmasovna Tashkent Medical Academy
  • Muxitdinova Tuxtaxon Kodirovna Andijan State Medical Institute

DOI:

https://doi.org/10.56121/2181-3612-2022-1-11-15

Keywords:

early menopause, premature menopause, women's quality of life, hormone replacement therapy

Abstract

Currently, the problem of early and premature menopause remains relevant due to the loss of fertility, reproductive function and a decrease in the quality of life of young women. The determination of clinical and hormonal predictors of the development of early/premature menopause and the development of a therapeutic and diagnostic algorithm for the management of women makes it possible to improve their quality of life.

References

McKinlay C.M. Normal transition to menopause: an overview. Maturitas 2017; 23 (2): 137-145.

Reynolds R.F., Obermeyer K.M. The age of natural menopause in Spain and the USA: results of the DAMES project. Am J Hum Biol 2015;17(3):331–340.

Lyubarsky J.L., Meyer P., Sowers M.F., Gould E.B., Santoro N. Premature menopause in a multi-ethnic population study of the transition to menopause. Hum Reprod 2018; 18 (1): 199-206.

Haller-Kikkatalo K., Ubo R., Kurg A., Salumets A. Prevalence and phenotypic characteristics of spontaneous premature ovarian insufficiency: a study based on the general population register. Hum Reprod 2015;30(5):1229–1238.

Mishra G.D., Pandeya N., Dobson A.J., Chan H.F., Anderson D., Kuh D. et al. Early menarche, absence of labor and the risk of premature and early natural menopause. Hum Reprod 2017;32(3):679–686.

Wu S, Cai X, Kallianpur A, Li X, Yang G, Gao J, etc. The effect of premature ovarian insufficiency on mortality and morbidity of Chinese women. PLoS One 2019; 9(3):e89597

Podfigurna-Stopa A., Chizhik A., Grimovich M., Smolarchik R., Katulsky K., Tchaikovsky K. et al. Premature ovarian insufficiency: the context of long-term consequences. J Endocrinol Invest 2016;39(9):983–990.

Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R. et al. The relationship of the age of the onset of menopause and the time elapsed since the beginning of menopause with cardiovascular outcomes, intermediate vascular signs and mortality from all causes: a systematic review and meta-analysis. // JAMA Cardiol 2016;1(7):767–776.

Kim YE, Park H, Jo MW, Oh IH, Go DS, Jung J et al. Trends and patterns of disease and injury burden in Korea using disability-adjusted life years. J Korean Med Sci 2019;34 Suppl 1:e75.

Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health effects of premature or early menopause and treatment considerations. Climacteric 2015; 18 (4): 483–491.

Girard R., Metro E., Thomas J., Pugey M., Ku S., Dreher J. K. Hormone therapy at the beginning of postmenopause increases prefrontal activity associated with cognitive control. // Scientific Representative 2017; 7 (1): 44917.

Tibiletti M.G., Testa G., Vegeta V., Alagna F., Taborelli M., Dalpra L., etc. Idiopathic forms of premature menopause and early menopause have the same genetic pattern. // Hum Reprod 2019;14(11):2731–2734.

Hoyos LR, Thakur M. Fragile X premutation in women: Recognition of health problems beyond primary ovarian insufficiency. J Assist Reprod Genet 2017;34(3):315–323.

Beck-Pecos P., Bersani L. Premature ovarian insufficiency. // Orphanet J Rare Dis 2016; 1 (1): 9.

Persani L, Rossetti R, Cacciatore C. Genes involved in premature ovarian insufficiency in humans. // J Mol Endocrinol 2018;45(5):257–279.

Hewlett M., Mahalingaya S. Updating of primary ovarian insufficiency. Curr Opin Endocrinol Diabetes Obes 2015;22(6):483–489.

Zakazhi A., Messi-Taylor N., Bodnar E.B. The relationship between some indicators of reproductive history, body obesity and menopausal transition in Hungarian women. // J Physiol Anthropol 2015;34(1):35.

Hardy R., Kuh D. Reproductive characteristics and age of the onset of perimenopause in the British national cohort. // Am J Epidemiol 2019;149(7):612–620.

Golden EB. The age at which the natural menopause occurs. // Obstet Gynecol Clin North Am 2020;38(3):425–440.

Forman M.R., Mangini L.D., Tellus-Jean R., Hayward M.D. The vital origin of the menarche and menopause ages. // Adolesc Health Med 2018; 4:1-21.

Chang SH, Kim CS, Lee KS, Kim H, Yim SV, Lim YJ et al, Premenopausal factors affecting premature ovarian insufficiency and early menopause. // Maturitas 2017; 58 (1): 19–30.

Yasui T., Hayashi K., Mizunuma H., Kubota T., Aso T., Matsumura Yu. et al. Factors associated with premature ovarian insufficiency, early menopause and earlier onset of menopause in Japanese women. // Maturitas 2019;72(3):249–255.

Hardy R., Kuh D. Social and environmental conditions throughout life and at the age of menopause in a British cohort study. // BJOG 2015; 112 (3): 346-354.

Luoto R., Caprio J., Uutela A. Age of natural menopause and socio-demographic status in Finland.Am J Epidemiol 2017;139(1):64–76.

Lawlor D.A., Ebrahim S., Smith G.D. The relationship of socio-economic status throughout life and the age of menopause: A British study of women's heart and health. // BJOG 2018; 110 (12): 1078–1087.

Kriplani A., Banerjee K. Review of the age of menopause in northern India. // Maturitas 2015; 52 (3-4): 199–204.

Kaczmarek M. The timing of natural menopause in Poland and related factors. // Maturitas 2017; 57 (2): 139–153.

Nichols H.B., Trendam-Dietz A., Hampton J.M., Titus-Ernstoff L., Egan K.M., Willett V.K. et al. From menarche to menopause: Trends among U.S. women born from 1912 to 1969. // Am J Epidemiol 2016;164(10):1003–1011.

Pakarinen M., Raitanen J., Kaaya R., Luoto R. The centuries-old trend of menopausal age in Finland in 2017-2018 and correlation with socio-economic, reproductive and lifestyle factors. // Maturitas 2010;66(4):417–422.

Wang D., Wang M., Cheng N., Zheng T., Hu S., Li H., et al. Exposure to sulfur dioxide and other factors affecting the age of onset of natural menopause in the Jinchuan cohort. // Climacteric 2015; 18 (5):722-732.

Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. // JAMA. 2006;295(17):2057–2071.

Webber L , Davies M , Anderson R, Bartlett J ., Braat D. et al. European Society for Human Reproduction and Embryology ESHRE Guideline: management of women with premature ovarian insufficiency // Hum Reprod. 2016;31(5):926-937. doi: 10.1093/humrep/dew027. Epub 2016 Mar 22.

Haller-Kikkatalo K., Uibo R., Kurg A., Salumets A. The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: A general population registry-based study // Human Reproduction 2015 30(5) P.1229–1238. DOI:10.1093/humrep/dev021

Gruber N, Kugler S, de Vries L, et al. Primary ovarian insufficiency nationwide incidence rate and etiology among Israeli adolescents. // J Adolesc Health. 2020; 66(5): 603–609, doi: 10.1016/j.jadohealth.2019.11.315,

Qin Y, Guo T, Li G, Tang TS, Zhao S, et al. CSB-PGBD3 Mutations Cause Premature Ovarian Failure.// PLoS Genet. 2015 Jul 28;11(7):e1005419. doi: 10.1371/journal.pgen.1005419. eCollection 2015 Jul.

Schoenaker DA, Jackson CA, Rowlands JV, Mishra GD. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. // Int J Epidemiol. 2014 Oct;43(5):1542-62. doi: 10.1093/ije/dyu094. Epub 2014 Apr 26.

Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. // Climacteric. 2016;19(1):27-36. doi: 10.3109/13697137.2015.1094784

Tao X, Jiang A, Yin L, Li Y, Tao F, Hu H. Body mass index and age at natural menopause: a meta-analysis. // Menopause. 2015 Apr;22(4):469-74. doi: 10.1097/GME.0000000000000324.

Costanian C, McCague H, Tamim H. Age at natural menopause and its associated factors in Canada: cross-sectional analyses from the Canadian Longitudinal Study on Aging. //Menopause. 2018 Mar;25(3):265-272. doi: 10.1097/GME.0000000000000990.

Mishra GD, Chung HF, Cano A, Chedraui P, Goulis DG, et al. EMAS position statement: Predictors of premature and early natural menopause. // Maturitas. 2019 May;123:82-88. doi: 10.1016/j.maturitas.2019.03.008. Epub 2019 Mar 13.PMID: 31027683

Anastasi JN. Premature ovarian failure: an update. // Fertil Steril. 2018; 70:

The ESHRE Guideline Group on POI, Webber L, Davies M, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. // Hum Reprod. 2016;31:926–937. doi:10.1093/humrep/dew027

Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. // J Clin Endocrinol Metab. 2014;99(10):3489–3510.

Ben-Nagi J, Panay N. Premature ovarian insufficiency: how to improve reproductive outcome? // Climacteric. 2019;17:342–346.

Moslehi, N., Mirmiran, P., Tehrani, F. R., & Azizi, F. Current evidence on associations of nutritional factors with ovarian reserve and timing of menopause: A systematic review. // Advances in Nutrition, 20178(4), 597–612.

Jamil, Z., Fatima, S. S., Ahmed, K., & Malik, R. Anti-mullerian hormone: Above and beyond conventional ovarian reserve markers. // Disease Markers, 2016, 5246217.

Published

2022-08-17

How to Cite

Nabiеva Д., Kayumova Д., and Muxitdinova Т. “CLINICAL AND PATHOGENETIC ASPECTS OF PREMATURE AND EARLY MENOPAUSE. WAYS OF CORRECTION”. Medical Science of Uzbekistan, no. 1, Aug. 2022, pp. 11-15, doi:10.56121/2181-3612-2022-1-11-15.

Issue

Section

Articles